White Paper

Found in translation

April 14, 2015

The cost of drug production has soared into the billions, presenting a huge barrier to companies hoping to market new medicines and creating a pressing need for more efficient development techniques. PerkinElmer’s Jens Hoefkens and Daniel Weaver discuss how translational medicine is simultaneously reducing expenses and improving the health of patients.

Download to find out more.